Novartis replaces top scientists at Avexis after drug data manipulated
August 14, 2019 at 15:57 PM EDT
Novartis AG said on Wednesday it replaced the two top research and development executives at its Avexis unit after some data was manipulated from early testing of a gene therapy for infants that costs more than $2 million.